HHealthcare Read More Gilead Sciences CEO Says HIV Prevention Drug Offers Clear ValueAugust 21, 2025 Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be…